Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Has results × vanucizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Paclitaxel 334 Carboplatin 326 pembrolizumab 325 Cisplatin 274 Gemcitabine 261 Docetaxel 248 Bevacizumab 238 Nivolumab 228 Pemetrexed 208 Rituximab 182 Dexamethasone 181 Cyclophosphamide 169 Capecitabine 169 Trastuzumab 149 Fluorouracil 145 Ipilimumab 120 Prednisone 117 Erlotinib Hydrochloride 116 atezolizumab 114 Oxaliplatin 108 Cetuximab 102 Sunitinib 101 Doxorubicin 97 Leucovorin 95 Lenalidomide 92 Irinotecan 88 130-nm albumin-bound paclitaxel 83 Bortezomib 77 durvalumab 75 Azacitidine 72

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02141295 2020-03-25

McCAVE

Hoffmann-La Roche

Phase 2 Terminated

197 enrolled 24 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡